FindTrial
Sign In

Shalparni Avapidan Nasya In Ardhavbhedaka

Efficacy Of Shalparni Avapidan Nasya In The Management Of Ardhavbhedaka - A Single Arm Study. - -

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/01/102196
Enrollment
55
Registered
2026-01-27
Start date
Unknown
Completion date
Unknown
Last updated
2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: G430- Migraine without aura

Interventions

None listed

Sponsors

Dr. Hitendra Atmaram Bhadane
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients showing classical lakshanas of Ardhavbhedaka.

Exclusion criteria

Exclusion criteria: 1) Patients of Ardhavbhedaka taking other treatment for other disease presently. 2) Patients suffering from Hypertension, DM, Hyper & Hypo Thyroidism, COPD and other chronic disease. 3) Patients suffering from secondary headaches like meningitis, brain tumor, encephalitis, cervical spondylosis, refractive errors & glaucoma. 4) Patients suffering from all types of sinusitis.

Design outcomes

Primary

MeasureTime frame
To study the aetiophathogenesis and progress of Ardhavbhedaka with special reference to diagnostic parameters of Ayurved texts.Timepoint: baseline, 1 week and 4 weeks.—

Secondary

MeasureTime frame
To study the procedure of Avapiodan nasya in details.Timepoint: baseline, 1 week and 4 weeks.—

Countries

India

Contacts

Public ContactDr Hitendra Atmaram Bhadane

LRP Ayurvedic Medical College, Hospital, Post Graduate Institute & Research Centre

dpkparida@yahoo.co.in8830333050

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 7, 2026